Table V.
Univariate analysis.
| Factors | Survival group (n=41) | Deceased group (n=15) | t/χ2 value | P-value |
|---|---|---|---|---|
| Age (years) | 0.020 | 0.889 | ||
| <50 | 20 (48.78) | 7 (46.67) | ||
| ≥50 | 21 (51.22) | 8 (53.33) | ||
| Sex | 0.448 | 0.503 | ||
| Male | 31 (75.61) | 10 (66.67) | ||
| Female | 10 (24.39) | 5 (33.33) | ||
| Smoking history | 0.034 | 0.854 | ||
| Yes | 18 (43.90) | 7 (46.67) | ||
| No | 23 (56.10) | 8 (53.33) | ||
| Differentiation | 5.130 | 0.024 | ||
| Undifferentiated | 7 (17.07) | 7 (46.67) | ||
| Low and moderately differentiated | 34 (82.93) | 8 (53.33) | ||
| Bone metastasis | 6.212 | 0.013 | ||
| Yes | 10 (24.39) | 9 (60.00) | ||
| No | 31 (75.61) | 6 (40.00) | ||
| Lymphatic metastasis | 2.574 | 0.040 | ||
| Yes | 10 (24.39) | 8 (53.33) | ||
| No | 31 (75.61) | 7 (46.67) | ||
| Local invasion of tumor | 4.743 | 0.029 | ||
| Yes | 14 (34.15) | 10 (66.67) | ||
| No | 27 (65.85) | 5 (33.33) | ||
| TNM staging | 17.598 | <0.001 | ||
| Stage I–II | 31 (75.61) | 2 (13.33) | ||
| Stage III–IV | 10 (24.39) | 13 (86.67) | ||
| miR-34a | 4.942±0.247 | 4.221±0.212 | 10.022 | <0.001 |
| Ki67 | 7.643±0.352 | 8.547±0.427 | 8.034 | <0.001 |